Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Continuous Glucose Monitoring
89%
Hospitalized Patients
79%
Type 2 Diabetic Patients
72%
Diabetes
40%
Diabetes Management
38%
Point-of-care Glucose
38%
Glucose Testing
34%
Randomized Controlled Trial
26%
Dysglycemia
26%
Intensive Care Unit Patients
25%
Hyperglycemia
22%
Non-intensive Care Unit
21%
Glucose Level
20%
Denmark
20%
Type 2 Diabetes Mellitus (T2DM)
19%
Hospital Diabetes
18%
Insulin Titration
18%
Titration Algorithm
14%
Glycemic Outcomes
14%
Hypoglycemia Risk
14%
Time in Range
14%
Insulin Dose
13%
Hypoglycemia
13%
Glycemic Variability
12%
Glycemic Status
11%
Patients with Diabetes
10%
International Guidelines
10%
Sliding Scale Insulin
10%
Monitoring Data
10%
Monitoring Metrics
10%
Insulin
9%
Glucose Monitoring
9%
Basal Insulin
9%
Acute Kidney Injury
9%
Type 1 Diabetes Mellitus (T1DM)
8%
Without Diabetes
8%
Inpatient Hyperglycemia
8%
Time below Range
8%
Hypoglycemic Events
8%
Hemoglobin A1c (HbA1c)
7%
Professional Confidence
7%
Professional Competencies
7%
COVID-19 Pandemic
7%
Exploratory Trial
7%
Community-acquired Pneumonia
7%
In-hospital Management
7%
Clinical Investigation
7%
Healthcare Professionals
7%
Readmission
7%
Pneumonia
7%
Nursing and Health Professions
Continuous Glucose Monitoring
100%
Patient with Type 2 Diabetes
73%
Intensive Care Unit
48%
Hypoglycemia
32%
Titrimetry
28%
Dysglycemia
26%
Non Insulin Dependent Diabetes Mellitus
24%
Glucose Level
22%
Hyperglycemia
19%
Insulin Dependent Diabetes Mellitus
19%
Glucose
16%
Practice Guideline
16%
Cohort Analysis
15%
Systematic Review with Meta-Analysis
15%
Confidence Interval
13%
Glucose Blood Level
13%
Post Hoc Analysis
13%
Systematic Review
11%
Antidiabetic Agent
11%
Hemoglobin A1c
9%
Health Care Personnel
9%
Acute Kidney Failure
9%
Meta Analysis
8%
Hospital Readmission
8%
Patient with Diabetes
8%
Outpatient
8%
Maturity Onset Diabetes of the Young
8%
Disease
7%
Hospital Management
7%
Community Acquired Pneumonia
7%
Limit of Detection
7%
Inflammation
7%
C Reactive Protein
7%
Grip Strength
7%
Clinical Outcome
7%
Charlson Comorbidity Index
6%
Thrombomodulin
6%
Insulin
6%
Diabetes Mellitus
5%
Insulin Treatment
5%
Hospital Mortality
5%
Medicine and Dentistry
Diabetes
66%
Intensive Care Unit
43%
Patient with Type 2 Diabetes
41%
Glycemic
36%
Dysglycemia
26%
Hypoglycemia
23%
Hyperglycemia
19%
Randomized Controlled Trial
17%
Cohort Analysis
15%
Systematic Review with Meta-Analysis
15%
Glucose
15%
Maturity Onset Diabetes of the Young
13%
Systematic Review
13%
Insulin
12%
Insulin Dependent Diabetes Mellitus
11%
Titrimetry
9%
Meta-Analysis
9%
Community-Acquired Pneumonia
7%
Arm
7%
Treatment Effect
7%
In Vitro
7%
Post-Hoc Analysis
7%
Glycemic Control
7%
Artificial Intelligence
7%
Antidiabetic Agent
7%
Charlson Comorbidity Index
6%
Hemoglobin A1c
6%
Thrombomodulin
6%
Insulin Treatment
5%
Injection
5%